Notify me when Polar Capital Holdings Plc files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NPCE | NeuroPace Inc | Common Stock, $0.001 par value per share | 9.1% | $34,534,675 | 2,972,003 | Polar Capital Holdings Plc | 31 Mar 2025 | ||
| HGTY | HAGERTY, INC. | Class A common stock, par value $0.0001 per share | 5.8% | $57,791,760 | 5,306,865 | Polar Capital Holdings Plc | 30 Jun 2025 | ||
| ELVN | ENLIVEN THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 5.2% | $56,952,978 | +$3,304,932 | 2,536,881 | +6.2% | Polar Capital Holdings Plc | 30 Jun 2025 |
| VSTM | Verastem, Inc. | Common stock, $0.0001 par value per share | 5.1% | $36,130,293 | 3,398,899 | Polar Capital Holdings Plc | 31 Dec 2025 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | Common Stock, par value $0.0001 | 4.2% | $75,147,145 | -$25,517,045 | 5,006,472 | -25% | Polar Capital Holdings Plc | 30 Jun 2025 |
| VTEX | VTEX | Class A common stock | 2.8% | $28,148,268 | 5,232,020 | Polar Capital Holdings Plc | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|